Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results 
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth 
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy 
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing 
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand 
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process 
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings 
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan 
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws 
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand 
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report 
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership 
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal 
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion 
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft 
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States 
SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO 
Pompano Beach, Fla., Dec. 07, 2015 (GLOBE NEWSWIRE) -- DS Healthcare today announced it has posted a letter to its shareholders. The letter can found by clicking here.
About DS Healthcare Group
DS Healthcare Group Inc. is a leader in the development of biotechnology for topical therapies. It markets through online channels, specialty retailers, distributors, pharmacies, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Health Group's flagship brand, visit www.dslaboratories.com or www.facebook.com/DS.Labs
Forward-looking statements
Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov
Investor Relations DS Healthcare Group (888) 404-7770 ext. 3 [email protected]
